Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

Synapse

Volumn 38, Issue 2, 2000, Pages 167-176

  Suzuki, Toshihito ^a   Abe, Shuzo ^a   Yamaguchi, Mika ^a   Baba, Atsuomi ^a   Hori, Takafumi ^a   Shiraishi, Hiroyasu ^a   Ito, Takehiko ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Dopamine; In vivo microdialysis; Nucleus accumbens; Sibutramine; Weight reducing drugs

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; PHENTERMINE; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; LOCOMOTION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMAL; APPETITE DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOBUTANES; DEXTROAMPHETAMINE; DOPAMINE; EATING; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHENTERMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033775196     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W     Document Type: Article

References (43)

1. Cholecystokinin elicits the complete behavioural sequence of satiety in rats
2. Long-term maintenance of weight loss after a very low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
3. Effects of phentermine on striatal dopamine and serotonin release in conscious rats: In vivo microdialysis study
4. Effects of sibutramine on DA and 5-HT release in rat striatum and hypothalamus in vivo and in vitro
5. Sibutramine produces dose-related weight loss
6. The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation
7. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats
8. Update on the pharmacotherapy of obesity
9. 3H]-5-HT uptake
10. 50) of an enzymatic reaction
11. Sibutramine: A new weight loss agent without evidence of the abuse potential associated with amphetamines
12. Thermogenic effects of sibutramine and its metabolites
13. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine
14. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
15. Functions of dopamine in the extrapyramidal and limbic systems: Clues for the mechanism of drug actions
16. On the preferential release of dopamine in the nucleus accumbens by amphetamine: Further evidence obtained by vertically implanted concentric dialysis probes
17. Obesity. Present and future pharmacological approaches
18. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: Sibutramine is a reuptake inhibitor
19. Effects in the rat of sibutramine in food intake and the behavioural satiety sequence
20. Sibutramine: A novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine
21. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents
22. A comparison of the effect of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: Evidence that dopamine is not a pharmacological target for sibutramine
23. 3H]-dopamine from superfused rat striatal slices: Predictive value for detecting stimulant drugs of abuse
24. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich part of the brain
25. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat
26. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat
27. The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens
28. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
29. Sibutramine: Weight loss in depressed patients
30. Monoamine release and uptake inhibition profiles of antiobesity agents
31. Hypothalamic serotonin: Pharmacological, biochemical and behavioural analyses of its feeding suppressive action
32. The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride
33. A practical computer-based approach to the analysis of radioligand binding experiments
34. Comparison of the effects of sibutramine, fluoxetine and d-fenfluramine on extracellular 5-HT in rat anterior hypothalamus: An in vivo microdialysis study
35. Co-administration of phentermine with d-fenfluramine causes additive effects on rat brain 5HT release in vivo and in vitro
36. CNS regulation of thermogenesis
37. The effect of selective lesioning of brain catecholamine-containing neurones on the activity of various anorectics in the rat
38. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats
39. d-Fenfluramine and phentermine both enhance central noradrenergic function via release - Contrast with reuptake inhibition by sibutramine
40. Sibutramine in weight control: A dose-ranging efficacy study
41. Effects of sibutramine or d-amphetamine on extracellular noradrenaline concentration in rat frontal cortex and hypothalamus
42. Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: Modulation by α2-adrenoceptors